{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:34:58Z","timestamp":1794958498546,"version":"4.9.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>Mucoepidermoid carcinoma (MEC) is generally characterized by an admixture of mucous, epidermoid and intermediate type cells. Numerous variants morphologies are described and defined by stromal and\/or cytoplasmic tinctorial characteristics. We now report 11 cases of MEC with serous acinar differentiation, reflecting a distal intercalated duct\/acinar phenotype, which we designate as mucoacinar carcinomas. Seven patients were female while 4 were male with a mean age of 55 years (range: 21 to 72\u2009y). Ten cases were from the parotid while 1 was from the submandibular gland. Mean size of the tumors was 1.8\u2009cm (range: 0.7 to 4.5\u2009cm). Three cases were low grade, 7 were intermediate grade, and 1 was high grade. Low to intermediate grade cases demonstrated prominent clear to vacuolated cells with focal serous acinar differentiation. The high-grade case showed a distinctive scattering of acinar cells interspersed between epidermoid cells. Periodic acid Schiff after diastase (9\/9), SOX-10 (9\/9), and DOG-1 (9\/10) highlighted the acinar component. Six of 7 cases showed a focal acinar predominant NR4A3 expression. <jats:italic toggle=\"yes\">MAML2<\/jats:italic> fluorescence in situ hybridization was positive in all cases, in both acinar and mucoepidermoid components. Two cases tested by next generation sequencing showed standard <jats:italic toggle=\"yes\">CRTC1-MAML2<\/jats:italic> fusions. <jats:italic toggle=\"yes\">MSANTD3<\/jats:italic> and <jats:italic toggle=\"yes\">NR4A3<\/jats:italic> fluorescence in situ hybridization on the other hand were negative. Evidence thus suggests that mucoacinar carcinoma represents an acinar variant morphology in MEC, rather than a true MEC-acinic cell carcinoma hybrid, or collision tumor. The acinar differentiation, SOX-10, DOG-1, and even focal NR4A3 reactivity may thus be diagnostic pitfalls.<\/jats:p>","DOI":"10.1097\/pas.0000000000001752","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T18:19:03Z","timestamp":1623003543000},"page":"1028-1037","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["Mucoacinar Carcinoma"],"prefix":"10.1097","volume":"45","author":[{"given":"Manish","family":"Bundele","sequence":"first","affiliation":[{"name":"Tang Tock Seng Hospital, Tang Tock Seng, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Weinreb","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine & Pathobiology, University Health Network, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simion","family":"Chiosea","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Faquin","sequence":"additional","affiliation":[{"name":"Massachussetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Dias-Santagata","sequence":"additional","affiliation":[{"name":"Massachussetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Leon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hyrcza","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja R.","family":"Seethala","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hed.23256","article-title":"Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients","volume":"36","author":"Chen","year":"2014","journal-title":"Head Neck"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ng1083","article-title":"t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway","volume":"33","author":"Tonon","year":"2003","journal-title":"Nat Genet"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/gcc.20522","article-title":"A new type of MAML2 fusion in mucoepidermoid carcinoma","volume":"47","author":"Fehr","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/PAS.0000000000000676","article-title":"MAML2 status in mucoepidermoid carcinoma can no longer be considered a prognostic marker","volume":"40","author":"Seethala","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.humpath.2011.02.028","article-title":"Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test","volume":"42","author":"Garcia","year":"2011","journal-title":"Hum Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.pap.0000213058.74509.d3","article-title":"Salivary mucoepidermoid carcinoma: revisited","volume":"13","author":"Luna","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF01606029","article-title":"Comparative histogenesis and morphogenesis of mucoepidermoid carcinoma and pleomorphic adenoma. An ultrastructural study","volume":"417","author":"Dardick","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2016.05.021","article-title":"SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma\/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma","volume":"56","author":"Hsieh","year":"2016","journal-title":"Hum Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/modpathol.2013.54","article-title":"SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis","volume":"26","author":"Ohtomo","year":"2013","journal-title":"Mod Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/modpathol.2012.57","article-title":"DOG1: a novel marker of salivary acinar and intercalated duct differentiation","volume":"25","author":"Chenevert","year":"2012","journal-title":"Mod Pathol"},{"key":"R11-20250608","first-page":"9214","article-title":"Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas","volume":"8","author":"Abd Raboh","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/PAS.0b013e3181de3021","article-title":"A reappraisal of the MECT1\/MAML2 translocation in salivary mucoepidermoid carcinomas","volume":"34","author":"Seethala","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cncy.22338","article-title":"Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma","volume":"129","author":"Skaugen","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/lary.22419","article-title":"Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: clinical implications","volume":"122","author":"Chiosea","year":"2012","journal-title":"Laryngoscope"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/PAS.0000000000001200","article-title":"The HTN3-MSANTD3 fusion gene defines a subset of acinic cell carcinoma of the salivary gland","volume":"43","author":"Andreasen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/1097-0142(19890315)63:6<1219::AID-CNCR2820630631>3.0.CO;2-Y","article-title":"Synchronous tumors arising in a single major salivary gland","volume":"63","author":"Gnepp","year":"1989","journal-title":"Cancer"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0964-1955(95)00059-3","article-title":"Hybrid tumours of salivary glands. Definition and classification of five rare cases","volume":"32B","author":"Seifert","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.MP.0000018977.18942.FD","article-title":"Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis","volume":"15","author":"Nagao","year":"2002","journal-title":"Mod Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1079-2104(98)90124-X","article-title":"Hybrid tumors or salivary gland tumors sharing common differentiation pathways? Reexamining adenoid cystic and epithelial-myoepithelial carcinomas","volume":"86","author":"Grenko","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/PAS.0000000000000990","article-title":"MYB translocation status in salivary gland epithelial-myoepithelial carcinoma: evaluation of classic, variant, and hybrid forms","volume":"42","author":"Bishop","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/1999-123-0698-HCOSG","article-title":"Hybrid carcinomas of salivary glands. Report of 4 cases and review of the literature","volume":"123","author":"Croitoru","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2559.1999.00761.x","article-title":"Hybrid carcinoma of the salivary gland: salivary duct adenocarcinoma adenoid cystic carcinoma","volume":"35","author":"Snyder","year":"1999","journal-title":"Histopathology"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00428-016-2018-6","article-title":"Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?","volume":"469","author":"Hellquist","year":"2016","journal-title":"Virchows Arch"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2559.2000.00976.x","article-title":"Intercalated duct hyperplasia: possible relationship to epithelial-myoepithelial carcinoma and hybrid tumours of salivary gland","volume":"37","author":"Chetty","year":"2000","journal-title":"Histopathology"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00428-015-1887-4","article-title":"Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma","volume":"468","author":"Rito","year":"2016","journal-title":"Virchows Arch"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1699-0463.1996.tb00693.x","article-title":"Combined acinic cell mucoepidermoid carcinoma of the parotid gland. Report of a case with immunohistochemical study","volume":"104","author":"Ballestin","year":"1996","journal-title":"APMIS"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41467-018-08069-x","article-title":"Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands","volume":"10","author":"Haller","year":"2019","journal-title":"Nat Commun"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/PAS.0000000000001494","article-title":"Nuclear NR4A2 (Nurr1) immunostaining is a novel marker for acinic cell carcinoma of the salivary glands lacking the classic NR4A3 (NOR-1) upregulation","volume":"44","author":"Haller","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/PAS.0000000000001279","article-title":"Nuclear NR4A3 immunostaining is a specific and sensitive novel marker for acinic cell carcinoma of the salivary glands","volume":"43","author":"Haller","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.pas.0000186394.64840.1d","article-title":"Sclerosing polycystic adenosis of the salivary gland: a report of 16 cases","volume":"30","author":"Gnepp","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0b013e3181a55c15","article-title":"Intercalated duct lesions of salivary gland: a morphologic spectrum from hyperplasia to adenoma","volume":"33","author":"Weinreb","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:00:35Z","timestamp":1749420035000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001752"}},"subtitle":["A Rare Variant of Mucoepidermoid Carcinoma"],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001752","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}